Elemental Diets vs. Semi-solid Diets on Gastric Excretion and Gastroesophageal Regurgitation
NCT02290626 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2015-11-03
Summary
Study 1: A randomized, crossover trial using elemental or semi-solid diets containing contrast medium as a tracer given to bedridden PEG patients. The distribution of the administered diets is assessed at the distal esophagus, proximal and distal stomach using a plain CT before and 1 hour after the administration.
Study 2: A randomized, crossover trial using elemental or semi-solid diets containing 13C sodium acetate as a tracer given to bedridden PEG patients. 13C breath tests are performed to estimate gastric emptying.
Conditions
- Gastro-oesophageal Reflux
Interventions
- DRUG
-
Elmental diet
elemental diet is administered using PEG.
- DRUG
-
Semi-solid diet
Semi-solid diet is administered using PEG.
Sponsors & Collaborators
-
Showa Inan General Hospital
lead OTHER
Principal Investigators
-
Akira Horiuchi, MD · Showa Inan General Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 20 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-11-30
- Primary Completion
- 2016-03-31
- Completion
- 2016-03-31
Countries
- Japan
Study Locations
More Related Trials
-
Sugammadex Versus Neostigmine for Reversal of Neuromuscular Blockade at the End of Kidney Transplantation Surgery
NCT03923556 ·Status: COMPLETED ·Phase: PHASE4
-
Diabetic Gastroparesis Efficacy/Safety Study of TZP-102
NCT01664637 ·Status: TERMINATED ·Phase: PHASE2
-
"Low Dose Sugammadex Combined With Neostigmine and Glycopyrrolate Versus Full Dose Sugammadex for Reversal of Rocuronium-induced Neuromuscular Blockade: a Cost Saving Strategy"
NCT02375217 ·Status: COMPLETED ·Phase: PHASE4
-
Gastric Electrical Stimulation (GES) and Pyloroplasty for the Treatment of Gastroparesis
NCT03123809 ·Status: COMPLETED ·Phase: NA
-
Gastric Pacemaker Implantation for Gastroparesis
NCT00568373 ·Status: WITHDRAWN ·Phase: NA
-
Safety and Efficacy of IV Infusion of Investigational Agent (TZP-101) in Patients With Severe Diabetic Gastroparesis
NCT00612014 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Study to Compare Smoflipid and Intralipid 20% in Pediatric Patients of 3 Months to 16 Years of Age
NCT03563222 ·Status: TERMINATED ·Phase: PHASE4
-
Intermittent Oro-Esophageal Tube Feeding vs. Nasogastric Tube Feeding in Infants With Pierre Robin Syndrome
NCT06178562 ·Status: TERMINATED ·Phase: NA
-
Trial- Dysphagia From ETT or GI Endoscopy
NCT02460055 ·Status: WITHDRAWN ·Phase: NA
-
Prospective Monocentric Study on the Efficacy of Lidocain Spray for Patient Comfort During Nasogastric Tube Insertion in Enteral Nutrition
NCT02022059 ·Status: COMPLETED ·Phase: PHASE3
-
Phase 2 Study of Velusetrag in Diabetic or Idiopathic Gastroparesis
NCT01718938 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, Acceptability, and Feasibility of Enterade®
NCT03782272 ·Status: TERMINATED ·Phase: NA
-
Study to Assess Efficacy and Safety of Lanreotide Autogel 120 MG in Treatment of Clinical Symptoms Associated With Inoperable Malignant Intestinal Obstruction
NCT02275338 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Methylprednisolone on the Reversal Time of Rocuronium by Sugammadex in the Pediatric Patient Group
NCT06623370 ·Status: COMPLETED ·Phase: PHASE4
-
Nocturnal Cyclic Enteral Nutrition Infusion Versus Continuous Infusion of Enteral Nutrition
NCT03727165 ·Status: WITHDRAWN ·Phase: NA
-
Evaluating the Safety and Efficacy of Tradipitant vs. Placebo in Idiopathic and Diabetic Gastroparesis
NCT04028492 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacological Reversal of Neuromuscular Blockade in Critically Ill Patients
NCT05993390 ·Status: RECRUITING ·Phase: NA
-
Steroid Versus Mitomycin-C Use in Pediatric Benign Recurrent Esophageal Stricture
NCT06626802 ·Status: COMPLETED ·Phase: NA
-
Feasibility Study to Evaluate Safety of Nutriseal™ Nutriplace™ System
NCT03371160 ·Status: TERMINATED ·Phase: NA
-
Thoracic Neuromodulation for Diabetic Gastroparesis
NCT05273788 ·Status: RECRUITING ·Phase: PHASE1
-
Comparison of Two Endoscopically Placed Nasojejunal Probes
NCT02705027 ·Status: UNKNOWN ·Phase: NA
-
Trial of Enteral Glutamine on Clinical Outcomes in Critically Ill Patients
NCT02998931 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of IV Infusion of Investigational Agent (TZP-101) in Patients With Diabetic Gastroparesis
NCT00639808 ·Status: COMPLETED ·Phase: PHASE1
-
Comparison of Sugammadex and Sugammadex-neostigmine Combination in the Antagonism of Moderate Neuromuscular Block
NCT05228223 ·Status: UNKNOWN ·Phase: NA
-
Elemental 028 Extra Case Studies
NCT06877923 ·Status: RECRUITING ·Phase: NA